NovoCure Ltd - Ordinary Shares, no par value per share (NVCR)

CUSIP: G6674U108

Q4 2020 13F Holders as of 31 Dec 2020

Type / Class
Equity / Ordinary Shares, no par value per share
Shares outstanding
112,245,592
Total 13F shares
74,207,296
Share change
+731,512
Total reported value
$12,840,473,582
Put/Call ratio
64%
Price per share
$173.04
Number of holders
348
Value change
+$248,693,042
Number of buys
206
Number of sells
117

Quarterly Holders Quick Answers

What is CUSIP G6674U108?
CUSIP G6674U108 identifies NVCR - NovoCure Ltd - Ordinary Shares, no par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NovoCure Ltd - Ordinary Shares, no par value per share (NVCR) as of Q4 2020

As of 31 Dec 2020, NovoCure Ltd - Ordinary Shares, no par value per share (NVCR) was held by 348 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 74,207,296 shares. The largest 10 holders included FMR LLC, BAILLIE GIFFORD & CO, Capital International Investors, VANGUARD GROUP INC, Capital World Investors, BlackRock Inc., STATE STREET CORP, CREDIT SUISSE AG/, MORGAN STANLEY, and PRICE T ROWE ASSOCIATES INC /MD/. This page lists 348 institutional shareholders reporting positions in this security for the Q4 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.